alemtuzumab (Campath) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

POSSIBLE SERIOUS SIDE EFFECTS:

Possible serious side effects include:

PREPARATIONS: Injection (single use vial): 30 mg/vial

DRUG INTERACTIONS: Alemtuzumab drug interaction studies have not been conducted.

PREGNANCY AND BREASTFEEDING SAFETY:

  • Proteins such as alemtuzumab, may cross the placental barrier and may be excreted in breast milk. Alemtuzumab has not been studied in pregnant women or nursing mothers. It should be given to a pregnant or nursing woman only if clearly needed.

STORAGE: Alemtuzumab should be stored at 2 C to 8 C (36 F to 46 F), protected from light, and not frozen. If frozen, thaw to 2 to 8 C before administration.

Medically Reviewed by a Doctor on 6/15/2016


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

Health Solutions From Our Sponsors